Michelle McSkane

1.9k total citations · 1 hit paper
10 papers, 1.2k citations indexed

About

Michelle McSkane is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Michelle McSkane has authored 10 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 2 papers in Pulmonary and Respiratory Medicine and 2 papers in Immunology. Recurrent topics in Michelle McSkane's work include Colorectal Cancer Treatments and Studies (4 papers), Nutrition, Genetics, and Disease (1 paper) and RNA modifications and cancer (1 paper). Michelle McSkane is often cited by papers focused on Colorectal Cancer Treatments and Studies (4 papers), Nutrition, Genetics, and Disease (1 paper) and RNA modifications and cancer (1 paper). Michelle McSkane collaborates with scholars based in United States, Italy and Germany. Michelle McSkane's co-authors include Heinz‐Josef Lenz, Ryuma Tokunaga, Martin D. Berger, Shivani Soni, Madiha Naseem, Alberto Puccini, Wu Zhang, Hideo Baba, Francesca Battaglin and Christine Brezden‐Masley and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Biochimica et Biophysica Acta (BBA) - Reviews on Cancer.

In The Last Decade

Michelle McSkane

10 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation – A target for novel cancer therapy

2017 981 citations Ryuma Tokunaga, Wu Zhang et al. Cancer Treatment Reviews profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michelle McSkane United States	5	596	555	323	180	161	10	1.2k
Yoshihiro Ohue Japan	16	723 1.2×	846 1.5×	329 1.0×	199 1.1×	108 0.7×	37	1.4k
Shigeki Chiba Japan	16	708 1.2×	925 1.7×	495 1.5×	242 1.3×	189 1.2×	34	1.7k
Maria L. Wikberg Sweden	16	928 1.6×	607 1.1×	569 1.8×	193 1.1×	304 1.9×	17	1.5k
Hannah M. Knochelmann United States	14	649 1.1×	542 1.0×	288 0.9×	126 0.7×	113 0.7×	28	1.1k
Kazuo Yasumoto Japan	15	616 1.0×	408 0.7×	436 1.3×	234 1.3×	149 0.9×	39	1.2k
Dalam Ly Canada	18	477 0.8×	913 1.6×	348 1.1×	180 1.0×	147 0.9×	30	1.4k
Laurence Bouchet‐Delbos France	21	337 0.6×	781 1.4×	277 0.9×	206 1.1×	68 0.4×	37	1.5k
Yuichiro Hatano Japan	20	432 0.7×	264 0.5×	403 1.2×	199 1.1×	144 0.9×	63	1.3k
Phyllis F. Cheung Hong Kong	19	330 0.6×	571 1.0×	303 0.9×	122 0.7×	132 0.8×	36	1.5k
Tan Jinquan China	19	418 0.7×	778 1.4×	356 1.1×	93 0.5×	90 0.6×	39	1.4k

Countries citing papers authored by Michelle McSkane

Since Specialization

Citations

This map shows the geographic impact of Michelle McSkane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle McSkane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle McSkane more than expected).

Fields of papers citing papers by Michelle McSkane

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle McSkane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle McSkane. The network helps show where Michelle McSkane may publish in the future.

Co-authorship network of co-authors of Michelle McSkane

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle McSkane. A scholar is included among the top collaborators of Michelle McSkane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle McSkane. Michelle McSkane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

King, Joshua D., et al.. (2023). The Impact of Non-opioid Analgesic Usage on Total Opioid Load During Traumatic Brain Injury Rehabilitation: A Retrospective Study. Cureus. 15(10). e46872–e46872. 2 indexed citations

McSkane, Michelle, Sebastian Stintzing, Volker Heinemann, et al.. (2018). Association Between Height and Clinical Outcome in Metastatic Colorectal Cancer Patients Enrolled Onto a Randomized Phase 3 Clinical Trial: Data From the FIRE-3 Study. Clinical Colorectal Cancer. 17(3). 215–222.e3. 4 indexed citations

Naseem, Madiha, Afsaneh Barzi, Christine Brezden‐Masley, et al.. (2018). Outlooks on Epstein-Barr virus associated gastric cancer. Cancer Treatment Reviews. 66. 15–22. 149 indexed citations

Battaglin, Francesca, Alberto Puccini, Madiha Naseem, et al.. (2018). Pharmacogenomics in colorectal cancer: current role in clinical practice and future perspectives. Journal of Cancer Metastasis and Treatment. 4(3). 12–12. 4 indexed citations

Battaglin, Francesca, Shu Cao, Joshua Millstein, et al.. (2018). Polymorphism in the circadian clock pathway to predict outcome in patients (pts) with metastatic colorectal cancer (mCRC): Data from TRIBE and FIRE-3 phase III trials.. Journal of Clinical Oncology. 36(15_suppl). 3576–3576. 2 indexed citations

Berger, Martin D., Sebastian Stintzing, Volker Heinemann, et al.. (2018). Genetic variations within the HER3 gene predict outcome for mCRC patients treated with first-line FOLFIRI/bevacizumab or FOLFIRI/cetuximab: Data from FIRE-3. Annals of Oncology. 29. viii18–viii18. 1 indexed citations

Puccini, Alberto, Martin D. Berger, Ryuma Tokunaga, et al.. (2018). Polymorphism in cancer-associated fibroblasts (CAFs) related genes and clinical outcome in metastatic colorectal cancer (mCRC) patients (pts) enrolled in two independent randomized phase III trials: TRIBE and FIRE-3.. Journal of Clinical Oncology. 36(4_suppl). 645–645. 1 indexed citations

Battaglin, Francesca, Joanne Xiu, Richard M. Goldberg, et al.. (2018). Circadian clock gene PER1 mutations in colorectal cancer (CRC).. Journal of Clinical Oncology. 36(15_suppl). 12106–12106. 2 indexed citations

Tokunaga, Ryuma, Wu Zhang, Madiha Naseem, et al.. (2017). CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation – A target for novel cancer therapy. Cancer Treatment Reviews. 63. 40–47. 981 indexed citations breakdown →

10.

Puccini, Alberto, Martin D. Berger, Madiha Naseem, et al.. (2017). Colorectal cancer: epigenetic alterations and their clinical implications. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1868(2). 439–448. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact